|
APRE Aprea Therapeutics Inc 1781983 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,287,917.00 |
| Balance Sheet |
|
Current Assets
|
$47,245,440.00 |
|
Assets
|
$47,612,387.00 |
|
Current Liabilities
|
$5,296,646.00 |
|
Liabilities
|
$3,950,821.00 |
|
Equity
|
$41,588,380.00 |
|
Shares Out
|
11982776.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,756,726.00 |
|
Investing Cash Flow
|
$-15,478.00 |
| Market Analysis |
Market Cap
|
$7,668,976.64 |
|
Price
|
$0.59 |
|
BVPS
|
3.47 |
|
PB
|
0.18 |
|
EPS
|
-0.22 |
|
FCF
|
$-2,772,204.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:45 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:45 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view APRE documents filed with the SEC.
APRE Filings
Clear
